373 related articles for article (PubMed ID: 12118543)
21. Combined modality treatment for stage III ovarian carcinoma.
Rizel S; Biran S; Anteby SO; Brufman G; Sulkes A; Milwidsky A; Weshler Z; Fuks Z
Radiother Oncol; 1985 Apr; 3(3):237-44. PubMed ID: 2988025
[TBL] [Abstract][Full Text] [Related]
22. Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study.
Gadducci A; Landoni F; Sartori E; Maggino T; Zola P; Gabriele A; Rossi R; Cosio S; Fanucchi A; Tisi G
Gynecol Oncol; 2001 May; 81(2):150-9. PubMed ID: 11330942
[TBL] [Abstract][Full Text] [Related]
23. Hyperfractionated split-course whole abdominal radiotherapy for ovarian carcinoma: tolerance and toxicity.
Kong JS; Peters LJ; Wharton JT; Ang KK; Delclos L; Gershenson DM; Copeland LJ; Edwards CL; Freedman RS; Saul PB
Int J Radiat Oncol Biol Phys; 1988 Apr; 14(4):737-43. PubMed ID: 3350729
[TBL] [Abstract][Full Text] [Related]
24. Sequential cisplatin/cyclophosphamide chemotherapy and abdominopelvic radiotherapy in the management of advanced ovarian cancer.
Green JA; Warenius HM; Errington RD; Myint S; Spearing G; Slater AJ
Br J Cancer; 1988 Nov; 58(5):635-9. PubMed ID: 3219276
[TBL] [Abstract][Full Text] [Related]
25. Cisplatin-containing versus cisplatin-free adjuvant chemotherapy in ovarian carcinoma. Results after second-look laparotomy.
Schneider J; Martin M; Erasun F; Matia JC; Rodriguez-Escudero FJ
Oncology; 1990; 47(2):109-11. PubMed ID: 2314822
[TBL] [Abstract][Full Text] [Related]
26. Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung.
Byhardt RW; Scott C; Sause WT; Emami B; Komaki R; Fisher B; Lee JS; Lawton C
Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):469-78. PubMed ID: 9806503
[TBL] [Abstract][Full Text] [Related]
27. Randomized phase I study of standard-fractionated or accelerated-hyperfractionated radiotherapy with concurrent cisplatin and vindesine for unresectable non-small cell lung cancer: a report of Japan Clinical Oncology Group Study (JCOG 9601).
Tsuchiya S; Ohe Y; Sugiura T; Fuwa N; Kitamoto Y; Mori K; Kobayashi H; Nakata K; Sawa T; Hirai K; Etoh T; Saka H; Saito A; Fukuda H; Ishizuka N; Saijo N;
Jpn J Clin Oncol; 2001 Oct; 31(10):488-94. PubMed ID: 11696618
[TBL] [Abstract][Full Text] [Related]
28. Adjuvant treatment for early ovarian cancer: a randomized phase III trial of intraperitoneal 32P or intravenous cyclophosphamide and cisplatin--a gynecologic oncology group study.
Young RC; Brady MF; Nieberg RK; Long HJ; Mayer AR; Lentz SS; Hurteau J; Alberts DS
J Clin Oncol; 2003 Dec; 21(23):4350-5. PubMed ID: 14645424
[TBL] [Abstract][Full Text] [Related]
29. Concurrent platinum-based chemotherapy and hyperfractionated radiotherapy with late intensification in advanced head and neck cancer.
Glicksman AS; Wanebo HJ; Slotman G; Liu L; Landmann C; Clark J; Zhu TC; Lohri A; Probst R
Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):721-9. PubMed ID: 9336155
[TBL] [Abstract][Full Text] [Related]
30. Intraperitoneal cisplatin-based chemotherapy vs. intravenous cisplatin-based chemotherapy for stage III optimally cytoreduced epithelial ovarian cancer.
Yen MS; Juang CM; Lai CR; Chao GC; Ng HT; Yuan CC
Int J Gynaecol Obstet; 2001 Jan; 72(1):55-60. PubMed ID: 11146078
[TBL] [Abstract][Full Text] [Related]
31. Primary treatment of stage III ovarian carcinoma with sequential chemotherapy and whole abdominal radiation therapy.
Reid GC; Roberts JA; Hopkins MP; Schoeppel SL; Perez-Tamayo C; Drescher C; Chamberlain D; Morley GW
Gynecol Oncol; 1993 Jun; 49(3):333-8. PubMed ID: 8314535
[TBL] [Abstract][Full Text] [Related]
32. Chemotherapy consisting of cisplatin, doxorubicin, and cyclophosphamide as an adjunct to surgery in stage Ic-II epithelial ovarian carcinoma. Gynecologic Oncology Group of the Comprehensive Cancer Center.
Wils J; van Geuns H
Am J Clin Oncol; 1989 Jun; 12(3):251-4. PubMed ID: 2658540
[TBL] [Abstract][Full Text] [Related]
33. Consolidation whole abdomen irradiation following adjuvant carboplatin-paclitaxel based chemotherapy for advanced uterine epithelial cancer: feasibility, toxicity and outcomes.
Rochet N; Kahn RS; Niemierko A; Delaney TF; Russell AH
Radiat Oncol; 2013 Oct; 8():236. PubMed ID: 24125168
[TBL] [Abstract][Full Text] [Related]
34. Radiation therapy in stage III ovarian cancer following surgery and chemotherapy: prognostic factors, patterns of relapse, and toxicity: a preliminary report.
Arian-Schad KS; Kapp DS; Hackl A; Juettner FM; Leitner H; Porsch G; Lahousen M; Pickel H
Gynecol Oncol; 1990 Oct; 39(1):47-55. PubMed ID: 2227572
[TBL] [Abstract][Full Text] [Related]
35. Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer.
Choi NC; Herndon JE; Rosenman J; Carey RW; Chung CT; Bernard S; Leone L; Seagren S; Green M
J Clin Oncol; 1998 Nov; 16(11):3528-36. PubMed ID: 9817271
[TBL] [Abstract][Full Text] [Related]
36. Treatment of early epithelial ovarian cancer with chemotherapy and abdominopelvic radiotherapy: results of a prospective treatment protocol.
Wong R; Milosevic M; Sturgeon J; Pintilie M; Fyles A; Levin W; Rosen B; Depetrillo D; Oza A; Manchul L; Murphy J; Chapman W
Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):657-65. PubMed ID: 10524420
[TBL] [Abstract][Full Text] [Related]
37. Sequential multi-agent chemotherapy and whole abdominal irradiation for stage III ovarian carcinoma.
Rosen EM; Goldberg ID; Rose C; Come S; Goldstein M; Simon L; Botnick LE
Radiother Oncol; 1986 Nov; 7(3):223-31. PubMed ID: 3809585
[TBL] [Abstract][Full Text] [Related]
38. Recurrent ovarian cancer. Effective radiotherapeutic palliation after chemotherapy failure.
Corn BW; Lanciano RM; Boente M; Hunter WM; Ladazack J; Ozols RF
Cancer; 1994 Dec; 74(11):2979-83. PubMed ID: 7525039
[TBL] [Abstract][Full Text] [Related]
39. Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588. Radiation Therapy Oncology Group. Eastern Cooperative Oncology Group.
Komaki R; Scott CB; Sause WT; Johnson DH; Taylor SG; Lee JS; Emami B; Byhardt RW; Curran WJ; Dar AR; Cox JD
Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):537-44. PubMed ID: 9336129
[TBL] [Abstract][Full Text] [Related]
40. [Multidisciplinary treatment of recurrent epithelial ovarian carcinoma and prognostic analysis].
Huang X; Cai SM; Tang J; Li ZT; Zang RY
Zhonghua Fu Chan Ke Za Zhi; 2004 Sep; 39(9):602-5. PubMed ID: 15498187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
